This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Risen (Suzhou) Pharma Tech Co., Ltd., Shanghai Junshi Biosciences Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Xiaolin He in Pharmaceutical Science
Introduction
Xiaolin He is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds aimed at treating joint and bone disorders. His work is characterized by a focus on innovative solutions that address common health issues.
Latest Patents
Xiaolin He holds a patent for glucosamine derivatives and their pharmaceutical uses. This patent includes compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof. These compounds are designed for the prevention or treatment of joint and bone disorders such as arthritis and osteoporosis. His innovative approach has the potential to improve the quality of life for many individuals suffering from these conditions.
Career Highlights
He is currently employed at Risen (Suzhou) Pharma Tech Co., Ltd., where he continues to advance his research and development efforts. His work at this company has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.
Collaborations
Xiaolin He has worked alongside colleagues such as Jiasheng Lu and Jiamin Gu. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of new pharmaceutical solutions.
Conclusion
Xiaolin He is a prominent figure in the pharmaceutical industry, with a focus on developing effective treatments for joint and bone disorders. His contributions through his patent and collaborative efforts highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile